Biotech News
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
ir.nurixtx.com2026-05-06 14:58 EST
BRISBANE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune diseases, today announced that